Cita APA

Schreck, K. C., Grossman, S. A., & Pratilas, C. A. (2019). BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors. Cancers (Basel).

Citación estilo Chicago

Schreck, Karisa C., Stuart A. Grossman, y Christine A. Pratilas. "BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors." Cancers (Basel) 2019.

Cita MLA

Schreck, Karisa C., Stuart A. Grossman, y Christine A. Pratilas. "BRAF Mutations and the Utility of RAF and MEK Inhibitors in Primary Brain Tumors." Cancers (Basel) 2019.